While the use of the Eμ-TCL1 transgenic mouse model to study the role of CD73 in CLL pathogenesis may not fully recapitulate human disease, our findings prompt further investigation of the therapeutic potential of targeting CD73 in CLL, especially in men. The gene discussed is NT5E; the disease is B-cell chronic lymphocytic leukemia.